The U.S. Food and Drug Administration announced it is reviewing a proposal to allow bemotrizinol in sunscreens sold in the United States.

BMY gets a priority FDA review for Opdivo's use in previously untreated advanced Hodgkin lymphoma, reinforcing its oncology ...

A first-of-its-kind law taking effect in December 2025 in New York state means more transparency around diaper ingredients ...

In early December 2025, Merck reported that the EMA’s Committee for Medicinal Products for Human Use recommended expanding WINREVAIR’s EU indication to cover adults with pulmonary arterial ...

The global Chelating / Sequestering Agents Market is on track for a decade of accelerated growth, reaching USD 4,023.1 million by 2035, up from USD 1,952.1 million in 2025, marking a substantial 193% ...

The Food and Drug Administration is moving closer to allowing a new sunscreen ingredient that is already used overseas. It’s called bemotrizinol.

Bemotrizinol sunscreens have been popular in other countries for years. The U.S. is finally looking to catch up.

News of a class-action lawsuit against Supergoop! sent shockwaves through the beauty world. The claim? That its bestselling ...

From skincare-infused makeup to 10-minute deliveries and tighter checks on SPF and ingredient claims, the beauty business entered a more demanding phase this year ...